Hypothyroidism and In Vitro Fertilization| Biomed Grid

Technological advancement in various form is one of the innovations that has revolutionarized medical practice in the 21st century compared to the early days of medical practice prior to the existence of Hippocrates. In vitro fertilization which has helped to solve the problem of infertility in some couple and individuals is one of such technological advancement innovations. In vitro fertilization is complex, expensive, invasive and time consuming, It involves harvesting ova (human female egg) and sperm from the male partner (or donor) and fertilizing (a process of bringing the ova in contact with the sperm so that the two can fuse to form a zygote (that is the embryo which over time develop into fetus which is born on maturity as a baby) outside the female reproductive system and outside the female body. The embryo is later implanted back in the female uterus (or a gestational carrier - a woman who has an embryo implanted in her uterus) for growth into fetus and a matured baby ready to be born. During the period outside the body, the ova, sperm and resultant embryo are temporarily free from the physiologic condition of the internal milieu including being free from the hormones that affects embryo and fetal growth indirectly by modulating maternal basal metabolic rate especially triiodothyronine and tetraiodothyronine. However, it is well documented in literature that there are cases of failed in vitro fertilization procedure in some cases occurring more than once in the same individual. Since personal or corporate resources involved in in vitro fertilization is substantial, then scientifically proven effort at finding the cause of infertility and establishing indication for in vitro fertilization should be well established and the effects such causes will have on the embryo post transfer into the uterus should be well envisaged with aim of preventing fetal loss.